KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Equity Income (2017 - 2019)

Biolife Solutions (BLFS) has disclosed Equity Income for 3 consecutive years, with -$291000.0 as the latest value for Q3 2019.

  • Quarterly Equity Income fell 576.74% to -$291000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was -$291000.0 through Dec 2020, up 60.68% year-over-year, with the annual reading at -$739000.0 for FY2019, 9.97% down from the prior year.
  • Equity Income for Q3 2019 was -$291000.0 at Biolife Solutions, down from -$217000.0 in the prior quarter.
  • The five-year high for Equity Income was -$43000.0 in Q3 2018, with the low at -$309000.0 in Q4 2018.
  • Average Equity Income over 3 years is -$219818.2, with a median of -$229368.0 recorded in 2017.
  • The sharpest move saw Equity Income surged 80.25% in 2018, then tumbled 576.74% in 2019.
  • Over 3 years, Equity Income stood at -$297792.0 in 2017, then dropped by 3.76% to -$309000.0 in 2018, then increased by 5.83% to -$291000.0 in 2019.
  • According to Business Quant data, Equity Income over the past three periods came in at -$291000.0, -$217000.0, and -$232000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.